Drupal.behaviors.print = function(context) {window.print();window.close();}>
Cancer Sequencing Takes off in 2011 Amid Debate on Benefits of Targeted vs. Comprehensive Approaches
January 11, 2012
Cancer Sequencing Takes off in 2011 Amid Debate on Benefits of Targeted vs. Comprehensive Approaches
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
At AACR, Early Providers of NGS-based Cancer Panels Debate 'Actionable' Mutations, Regulatory Issues
April 10, 2013 / Clinical Sequencing News
Entering NGS Space, Asuragen Launches Cancer Panels Optimized for FFPE on Ion Torrent and GA
January 4, 2012 / Clinical Sequencing News
Asuragen Launches Cancer Panels Optimized for FFPE Tissue; Plans to Sell Proprietary Reagents
April 10, 2013 / Clinical Sequencing News
Oxford Group Launches PGM-Based Cancer Test under UK's Stratified Medicine Program
January 2, 2013 / Clinical Sequencing News
CHOC Employs Illumina's RapidTrack, Complete Genomics to Test WGS in Pediatric Cancer Cases
August 22, 2012 / Clinical Sequencing News